KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $8.6 billion.

  • Johnson & Johnson's Accumulated Expenses rose 52.64% to $8.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $8.6 billion, marking a year-over-year increase of 52.64%. This contributed to the annual value of $8.6 billion for FY2025, which is 52.64% up from last year.
  • Johnson & Johnson's Accumulated Expenses amounted to $8.6 billion in Q4 2025, which was up 52.64% from $7.6 billion recorded in Q3 2025.
  • In the past 5 years, Johnson & Johnson's Accumulated Expenses registered a high of $14.0 billion during Q1 2021, and its lowest value of $7.4 billion during Q2 2025.
  • For the 5-year period, Johnson & Johnson's Accumulated Expenses averaged around $10.9 billion, with its median value being $10.6 billion (2023).
  • As far as peak fluctuations go, Johnson & Johnson's Accumulated Expenses skyrocketed by 4377.77% in 2021, and later crashed by 3361.57% in 2025.
  • Over the past 5 years, Johnson & Johnson's Accumulated Expenses (Quarter) stood at $13.8 billion in 2021, then dropped by 13.46% to $12.0 billion in 2022, then fell by 14.57% to $10.2 billion in 2023, then fell by 16.28% to $8.5 billion in 2024, then grew by 0.53% to $8.6 billion in 2025.
  • Its Accumulated Expenses was $8.6 billion in Q4 2025, compared to $7.6 billion in Q3 2025 and $7.4 billion in Q2 2025.